Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PARATHYROID HORMONE
- The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus
- Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients
- Study of the PTH-independent Effects of Encaleret on Mineral Homeostasis in Subjects With Postsurgical Hypoparathyroidism (PSH)
- The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and Hypocalcaemia
- Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
- SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients
- Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
- Denosumab Treatment in CKD Patients at High Risk of Fracture
- Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) Associated Alopecia Areata
- Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy
- Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
- The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With Tenofovir Disoproxil Fumarate
- Effectiveness of Vitamin C Supplementation in Treatment of Rickets
- Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial
- AZP-3601 SAD and MAD Study in Healthy Subjects and Subjects With Hypoparathyroidism
- Prevention of Postoperative Hypocalcemia of Oral Vitamin D Supplementation Before Total Thyroidectomy
- Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule
- A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults
- Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture
- Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease
- Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
- Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers
- Vitamin D Metabolism in Patients With Endocrine Disorders
- Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
- Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
- Supracondylar Distal Femur Fractures and Abaloparatide
- Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen
- Fracture Recovery for Returning to Duty (Teriparatide STRONG)
- Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics, and Efficacy of CLTX-305 in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
- The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients.
- High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy
- The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip
- Abaloparatide and Pelvic Fracture Healing
- Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial
- Effect of Topical Melatonin Application on Dental Implant Osseointegration and Marginal Bone Level
- Study of Teriparatide in Stress Fracture Healing
- Alendronate Versus Denosumab in Kidney Transplant Patients
- Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers
- Novel Combination Therapy for Osteoporosis in Men
- The Effect of Etelcalcetide on CKD-MBD
- Comparison of the Impact of Diet vs Thiazide in BMD in Children With Idiopathic Hypercalciuria
- A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism
- Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients
- Systematic Administration of Calcium and Vitamin D After Thyroidectomy
- Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
- Effect of Abaloparatide on Lumbar Disc Degeneration
- Study of Etelcalceide in Pediatric Subjects With Secondary Hyperparathyroidism and CKD on Hemodialysis
- Cholecalciferol on Hemodialysis Patients
- Endocrine Response of the Organism to Polytrauma
- Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
- Denosumab Treatment for Fibrous Dysplasia
- Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.
- Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism
- The Kampala Women's Bone Study
- Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction
- 25-Hydroxyvitamin D Pharmacokinetic Study
- The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH
- A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
- Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
- Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
- Hyperphosphatemia in Children With Chronic Kidney Disease
- Healthy Combine Study
- Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
- The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
- Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study
- Theophylline Treatment for Pseudohypoparathyroidism
- Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
- Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
- Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
- Individualized Response to Vitamin D Treatment Study
- Cardiovascular Effects of Empagliflozine
- A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
- Genetics of Response to Canagliflozin
- Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved?
- Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.
- Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
- Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism
- Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
- Vitamin D Treatment for Painful Diabetic Neuropathy
- Vitamin D Levels Following Topical Application of Vitamin D Ointment
- PTH And Calcium Responses to Exercise in Older Adults Experiment 2 (PACE Sr. 2)
- Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
- PTH and Vibration in OSteoporosis Study
- Montelukast for Treatment of Uremic Pruritus
- Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
- A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen
- Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism
- Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers
- Determination of Vitamin D Dose to Maintain Sufficiency Amongst Indian and Malay Women in the Tropics
- Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption
- The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
- Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss
- Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002
- Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
- Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
- Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy
- Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation
- Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
- Phophate Lowering Trial
- Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)
- Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis
- Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?
- The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
- The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone
- Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot
- Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients
- Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition
- Fosrenol Post-marketing Surveillance in Japan
- Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
- Preventing Health Disparities During Pregnancy Through Vitamin D Supplementation
- The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
- A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
- Release of Osteogenic Markers in Immediately and Non-loaded Dental Implants
- Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
- OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism
- The Effect of Vitamin D Supplementation in Type 2 Diabetes
- Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
- The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
- Parathyroid Hormone for the Treatment of Humerus Fractures
- The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta
- Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients
- Stem Cell Recruitment in Osteoporosis Therapy
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
- Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy Participants
- Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder
- Vitamin D Deficiency and Postoperative Hypocalcemia
- Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients
- Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis
- Fosrenol and Phosphorus Balance - Lanthanum Carbonate
- Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
- Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
- Denosumab in Primary Hyperparathyroidism
- Vitamin D Metabolism in Chronic Kidney Disease Patients
- Interaction Between a Calcimimetic Agent and the Renin Angiotensine Aldosterone System
- A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
- Treatment With PTH After Sternotomy in Cardiac Surgery Patients
- A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary
- Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation
- Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
- Determination of Effective Vitamin D Replacement and Monitoring Strategies in Vitamin D Deficiency State
- Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
- Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5
- The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
- Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
- Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
- Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
- One Week Comparison Study of PTH and PTHrP Infusions
- The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study
- Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women
- Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur
- Vitamin D Repletion in Primary Hyperparathyroidism
- A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)
- Vitamin D Supplementation in Chronic Stable Heart Failure
- The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone
- Pediatric Chronic Kidney Disease Safety and Efficacy
- Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)
- Effect of Vitamin D on Metabolic Parameters in Patients With the Metabolic Syndrome
- Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
- FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease
- Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism
- HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism
- Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
- Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
- Teriparatide for Postsurgical Hypoparathyroidism
- Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes
- Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery
- Effects of Spironolactone in Dialysis
- Evaluation of a Cincalcet Suppression Test
- Trial to Optimize Mineral Outcomes in Dialysis Patients
- Study of Vitamin D and Effect on Heart Disease and Insulin Resistance
- Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease
- Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density
- Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)
- Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
- Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
- Vitamin D Supplementation After Parathyroid Surgery
- Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
- Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
- Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo
- Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients
- Vitamin D in Postmenopausal Women at High Risk for Breast Cancer
- Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer
- Racial Differences in Phosphorus Metabolism
- ADD-ON Study to Existing Hypoparathyroidism Studies
- Comparison Study of PTHrP and PTH to Treat Osteoporosis
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
- Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
- Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)
- Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
- Dose-dependent Anti-inflammatory Effects of Vitamin D in a Human Gingivitis Model
- The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
- Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
- Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism
- Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
- Use of NPSP558 in the Treatment of Hypoparathyroidism
- Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
- Cholecalciferol Supplementation, Muscle Strength
- Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
- A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
- Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer
- Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
- Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis
- Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
- Use of Teriparatide to Accelerate Fracture Healing
- A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis
- One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
- Vitamin D 2 to Dialysis Patients
- The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
- The Effect of Calcium and Vitamin D in Patients With Heart Failure
- Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis
- Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
- Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
- Bone Properties in Hypoparathyroidism: Effects of PTH
- The Pharmacokinetics of a Single Large Dose of Vitamin D3
- Treatment of Secondary Hyperparathyroidism in the Uremic Patient
- Improving Vitamin D Status In Cystic Fibrosis
- Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
- Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
- Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
- Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
- Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
- Vitamin D Status of Pregnant Women and Their Children in Eau Claire, South Carolina
- Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate Asthma
- Effects of PTH Replacement on Bone in Hypoparathyroidism
- Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
- Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients
- Very Low Protein Diet or Dialysis in Uremic Elderly?
- Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants
- 7 Day Continuous Parathyroid Hormone IV Infusion
- A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo
- Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)
- An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate
- The Effects of Potassium Citrate on Bone Metabolism
- The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL
- Magnesium Supplementation to Prevent Bone Loss
- E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
- Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients
- Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
- Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
- Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
- Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
- Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
- Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
- Impact of Parathyroid Hormone (PTH) on Osseous Cavity
- Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
- Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
- 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
- Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
- EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
- Vitamin D Administration in the Nursing Home
- Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
- "PTHrP(1-36) IV Dose Escalation Study"
- Calcium Supplementation in Postmenopausal Women
- Open Label Extension Study of PREOS
- A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
- TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
- rhPTH Therapy for Low Turnover Bone Fragility
- ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism
- START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
- Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta
- S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
- Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure
- The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients
- Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
- Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
- A Research Study for Patients With End-Stage Renal Disease (ESRD)
- Osteopenia and Renal Osteodystrophy: Evaluation and Management
- Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
- Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
- An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass
- Once Weekly Parathyroid Hormone for Osteoporosis
- Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis
- An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
- PTHrP and Osteoporosis
- Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
- Treatment of Psoriasis With Parathyroid Hormone
- Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
- PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
- Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
- Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
- Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
- Phase II Study of Calcitonin for Tumoral Calcinosis
- Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis
- Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
- Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34
- Studies of Elevated Parathyroid Activity
- Oral Calcium in Pregnant Women With Hypertension
- Effects of Parathyroid Hormone in Men With Osteoporosis
- Alendronate and/or Parathyroid Hormone for Osteoporosis
Clinical trials list
click for details